Ghavidel Farideh, Moalefshahri Razieh, Javid Hossein, Rezagholinejad Nastaran, Hashemy Seyed Isaac
Department of Clinical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Department of Medical Laboratory Sciences, Varastegan Institute for Medical Sciences, Mashhad, Iran.
Curr Med Chem. 2025;32(11):2142-2155. doi: 10.2174/0929867331666230821110418.
Several investigations have revealed that nasopharyngeal carcinoma (NPC), earlier known as lymphoepithelioma, originates from the nasopharynx epithelium (NPE). The global NPC incidence and mortality distribution reports have reported very high rates (more than 20-30 men per 100,000 men and 10 women per 100,000). Genetic background susceptibilities, Epstein-Barr virus (EBV), and their complex interaction are expressed as the pathophysiology. Also, radiotherapy of locoregional lesions is the main treatment for NPC because of the extremely radiosensitive feature of the non-keratinizing variety. On the other hand, surgical intervention might be used for recurrent situations, while simultaneous radiation and chemotherapy for advanced stages are preferable. Since specific disease symptoms do not appear early, biomarkers should be identified to facilitate diagnosis. As overexpression of heat shock proteins (HSPs) has been observed in various cancers, they can be a promising candidate biomarker for many malignancies. The purpose of this study was to peruse different pathogenic roles of a panel of HSPs, including their diagnostic, preventive, and remedial role in NPC, which may provide the basis for future discoveries of novel HSP-based biomarkers of NPC.
多项研究表明,鼻咽癌(NPC),早期称为淋巴上皮瘤,起源于鼻咽上皮(NPE)。全球鼻咽癌发病率和死亡率分布报告显示发病率很高(每10万名男性中超过20 - 30例,每10万名女性中10例)。遗传背景易感性、爱泼斯坦 - 巴尔病毒(EBV)及其复杂相互作用表现为病理生理学特征。此外,由于非角化型鼻咽癌对放疗极其敏感,局部区域病变的放射治疗是鼻咽癌的主要治疗方法。另一方面,手术干预可用于复发病例,而晚期病例则首选同步放化疗。由于特定疾病症状出现较晚,应确定生物标志物以促进诊断。鉴于在各种癌症中均观察到热休克蛋白(HSPs)的过表达,它们可能是许多恶性肿瘤有前景的候选生物标志物。本研究的目的是探究一组热休克蛋白的不同致病作用,包括它们在鼻咽癌中的诊断、预防和治疗作用,这可能为未来发现基于热休克蛋白的新型鼻咽癌生物标志物提供依据。